Dynamic Contrast-Enhanced CT Characterization of Xp11.2 Translocation/TFE3 Gene Fusions versus Papillary Renal Cell Carcinomas

Figure 4

Dynamic contrast enhancement patterns of Xp11.2 RCC, type 1 and 2 PRCCs. Xp11.2 RCC: renal cell carcinoma associated with Xp11.2 translocation/TFE3 gene fusions; PRCC: papillary renal cell carcinoma; UP: unenhanced phase; CP: corticomedullary phase; NP: nephrographic phase; DP: delayed phase; HU: Hounsfield unit.